|
Can’t access the links? Add “lnks.gd” to the allowlist of your content blocking software. |
|
|
The Washington State Health Care Authority is seeking applications from interested physicians to fill an opening on the Washington State Pharmacy and Therapeutics (P&T) Committee beginning on February 1, 2026.
The purpose of the committee is to evaluate the available evidence of the relative safety, efficacy, and effectiveness of prescription drugs within a class of prescription drugs and make recommendations to the appointing authority for its deliberation in the development of the Washington preferred drug list established in RCW 70.14.050. The P&T Committee also serves as the Apple Health (Medicaid) Drug Utilization Review (DUR) Board. The DUR Board does a similar evaluation of drug classes for the Apple Health preferred drug list.
The initial term of appointment is three years. Members of the committee are expected to attend four full day virtual meetings a year, with a few hours of reading to prepare for the meeting. Members of the committee will be compensated for attendance at meetings in accordance with a personal services contract executed after appointment to the committee.
|
|
|
|
